Different pathways for iNOS-mediated toxicity in vitro dependent on neuronal maturation and NMDA receptor expression

Journal of Neurochemistry

Volumn 82, Issue 2, 2002, Pages 269-282

  Golde, Sabine ^a,c   Chandran, Siddharthan ^a,c   Brown, Guy C ^b   Compston, Alastair ^a,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Inflammation; iNOS; Microglia; Neurotoxicity; Nitric oxide; NMDA receptor

Indexed keywords

2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; DIZOCILPINE; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE SYNTHASE; TACROLIMUS;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; ENZYME RELEASE; INFLAMMATION; MICROGLIA; NERVE CELL NECROSIS; NERVE INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0036062517     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.00973.x     Document Type: Article

References (65)

1. Glial cells in neurotoxicity development
2. 5-(1 -Imino-3-butenyl)-L-omithine. A neuronal isoform selective mechanism-based inactivator of nitric oxide synthase
3. Reactive oxygen intermediates as second messengers of a general pathogen response
4. Nitric-oxide-induced necrosis and apoptosis in PC 12 cells mediated by mitochondria
5. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity
6. Surveillance, intervention and cytotoxicity: Is there a protective role of microglia?
7. Cytotoxicity of microglia
8. Reactions of nitric oxide, superoxide and peroxynitrite with superoxide dismutase in neurodegeneration
9. The neuronal death induced by endotoxic shock but not that induced by excitatory amino acids requires TNF-alpha
10. Microglial produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death
11. Nitric oxide donors, nitrosothiols and mitochondrial respiration inhibitors induce caspase activation by different mechanisms
12. Mechanisms of nitric oxide-dependent apoptosis: Involvement of mitochondrial mediators
13. Nitric oxide, mitochondria, and cell death
14. Nitric oxide produced by activated astrocytes rapidly and reversibly inhibits cellular respiration
15. Transcellular regulation of cell respiration by nitric oxide generated by activated macrophages
16. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism
17. Interleukin-1 and tumor necrosis factor-α synergistically mediate neurotoxicity: Involvement of nitric oxide and of N-methyl-D-aspartate receptors
18. Persistent inhibition of cell respiration by nitric oxide: Crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione
19. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures
20. Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures
21. The modulation of IL-6 and TNFα release by nitric oxide following stimulation of J774 cells with LPS and IFNγ
22. Macrophages in CNS remyelination: Friend or foe?
23. Microglial tissue plasminogen activator (tPA) triggers neuronal apoptosis in vitro
24. Nitric oxide signalling in the central nervous system
25. 1400 W is a slow, tight binding, and highly selective inhibitor of inducible nitric oxide synthase in vitro and in vivo
26. Microglia and the immune pathology of Alzheimer's disease
27. Characterization of amoeboid microglia isolated from developing mammalian brain
28. Brain glia release factors with opposing actions upon neuronal survival
29. Nitric oxide, mitochondria and neurological disease
30. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer's disease
31. Time dependency of the action of nitric oxide in lipopolysaccharide-intefferon-γ-induced neuronal cell death in murine primary neuron-glia co-cultures
32. Betel nut constituents as inhibitors of γ-aminobutyric acid
33. Pathways to neuronal injury and apoptosis in HIV-associated dementia
34. Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: Role of microglia
35. Apoptotic pathways mobilized in microglia and neurones as a consequence of chromogranin A-induced microglial activation
36. Peroxynitrite and nitric oxide donors induce neuronal apoptosis by eliciting autocrine excitotoxicity
37. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease
38. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
39. The inflammatory response system of brain: Implications for therapy of Alzheimer's and other neurodegenerative diseases
40. Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease
41. Arthritis and antiinflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies
42. Selective killing of cholinergic neurones by microglial activation in basal forebrain mixed neuronal/glial cultures
43. Nitric oxide causes glutamate release from brain synaptosomes
44. Interferonγ plus lipopolysaccharide induction of delayed neuronal apoptosis in rat hippocampus
45. Activation of microglial cells by beta-amyloid protein and interferon-gamma
46. 2+)-independent synaptic vesicle release
47. A comparative immunohistochemical study of Kuru and senile plaques with a special reference to glial reactions at various stages of amyloid plaque formation
48. Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex
49. Production of nitric oxide by glial cells
50. Murine brain macrophages induce NMDA receptor mediated neurotoxicity in vitro by secreting glutamate
51. Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurones involves excitatory amino acids rather than reactive oxygen intermediates and cytokines
52. Molecular signals for glial activation: Pro- and anti-inflammatory cytokines in the injured brain
53. Neurotoxic responses by microglia elicited by excitotoxic injury in the mouse hippocampus
54. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsin-remitting MS
55. Nitric oxide potently and reversibly deenergizes mitochondria at low oxygen tension
56. Immunoglobulins for intravenous use inhibit TNFα cytotoxicity in vitro
57. Risk of Alzheimer's disease and duration of NSAID use
58. Nitric oxide-dependent damage to neuronal mitochondria involves the NMDA receptor
59. Vicious cycle involving Na+ channels, glutamate release, and NMDA receptors mediates delayed neurodegeneration through nitric oxide formation
60. Axonal transection in the lesions of multiple sclerosis
61. Reactive microglia specifically associated with amyloid plaques in Alzheimer's disease brain tissue express melanotransferrin
62. 2+-induced apoptosis through calcineurin dephosphorylation of BAD
63. Nitric oxide induces oxidative stress and apoptosis in neuronal cells
64. Nitric oxide activation of poly (ADP-ribose) synthetase in neurotoxicity
65. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS